Accompanied by director of biomedicine office of Xi’an High-tech Industrial Development Zone, Dr.Wang Minghan, founder and president of American Baoxiang science and technology company and professor of China’s Medium-and Long-Term Talent Development Plan visits Xi’an Libang enterprise R&D center.

Mr.Ju jianbo, CEO and Mr.Fu Jingguo, vice president of Xi’an Libang Healthcare Group accompanied Dr. Wang Minghan to visit Xi’an Libang enterprise R&D center. Mr. Ju Jianbo gave a detailed introduction on the featured products and their R&D situation, including Propofol Injection, Alprostadil Injection, Medium and Long Chain Fat Emulsion Injection, medical devices “Non-invasive Continuous Instantaneous Blood Pressure Monitor and Donning Sterile Gloves Machine, what’s more, Mr.Ju jianbo presented on Libang’s self-developed new drug-LMR-101 and Long-acting Ropivacaine Injection in detail. After having listened to the R&D situation and future plan of Libang Enterprise, Dr.Wang Minghan fully agreed with innovative ideas.

Soon afterwards, Dr.Wang Minghan had in-depth exchange of views on the issues of international development of pharmacy, domestic and overseas advanced technology, supporting policies of funds for new drug clinical tests, and other related problems such as the government supporting policies. And he spoke highly of the incubation, transfer and success of Libang’s innovation project; besides, he also praised the operation strategy such as the integration of "Internet+"and biological medicine.

  Character Introducion:

  Early having studied abroad in the United States, Dr. Wang Minghan, former vice president of Johnson & Johnson pharmaceutical, once in charge of the biopharmaceuticals and chemical drug business in the area of international metabolic disease, has always been a leading figure of international metabolic disease in the pharmaceutical field. He has a high prestige in the world of pharmaceutical engineering and academia and he also serves as the judge of China’s Medium-and Long-Term Talent Development Plan and the evaluation professor of numerous international academic journals and scientific research fund.